Miryam Liberman Inc is categorized under Internal Medicine Doctors in Westlake Village, CA and active since 1982.
Miryam Liberman Inc was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Miryan S Liberman at the company’s single location by writing to 31822 Village Center Road # 107, Westlake Village, California CA 91361 or by phoning (818) 991-7315. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Miryam Liberman Inc |
Contact Person: | Miryan S Liberman |
Address: | 31822 Village Center Road # 107, Westlake Village, California 91361 |
Phone Number: | (818) 991-7315 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1982 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Miryam Liberman Inc was started in 1982 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Miryan S Liberman for inquiries that concern Miryam Liberman Inc by calling the company number (818) 991-7315, as your correspondence is most welcome. Additionally, the physical location of the single location of Miryam Liberman Inc can be found at the coordinates 34.146674,-118.81573 as well as the street address 31822 Village Center Road # 107 in Westlake Village, California 91361.
For its online presence, you may visit Miryam Liberman Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.